Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Pseudomonas aeruginosa flagellar motility machinery is a complex, multi-protein nanomachine that drives swimming and swarming motility, enabling the bacterium to navigate environments and colonize host tissues. It consists of a basal body anchored in the cell envelope, a hook, and a long extracellular filament composed of flagellin (FliC), powered by two distinct stator complexes, MotAB and MotCD (Lovewell et al., 2014; Gabrilska et al., 2024). Beyond locomotion, the flagellum serves as a critical virulence factor by facilitating initial attachment to surfaces and triggering host innate immune responses through Toll-like receptor 5 (TLR5) and the NLRC4 inflammasome (Lovewell et al., 2014). In clinical development, this machinery is targeted by anti-virulence strategies, such as monoclonal antibodies and vaccines, which aim to neutralize flagellin or inhibit motor function to prevent bacterial dissemination and biofilm formation (Saha et al., 2007). However, therapeutic intervention must account for the fact that P. aeruginosa often loses motility during chronic infections to evade phagocytic clearance and form antibiotic-tolerant aggregates (Gabrilska et al., 2024). Consequently, targeting the flagellar machinery is primarily relevant for acute infections or as a prophylactic measure to prevent the transition to a chronic, sessile state.
Inhibition of flagellar assembly, disruption of motor rotation, or neutralization of flagellin to prevent host cell attachment and TLR5-mediated inflammation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudomonas aeruginosa flagellar motility machinery (P. aeruginosa flagellum).